Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Pulse Biosciences (PLSE) Shares Issued (2020 - 2025)

Pulse Biosciences has reported Shares Issued over the past 6 years, most recently at $12.0 million for Q4 2025.

Quarterly results put Shares Issued at $12.0 million for Q4 2025, up 120.42% from a year ago — trailing twelve months through Dec 2025 was $153.1 million (up 17474.63% YoY), and the annual figure for FY2025 was $14.1 million, up 1518.83%.
Shares Issued for Q4 2025 was $12.0 million at Pulse Biosciences, down from $63.5 million in the prior quarter.
Over the last five years, Shares Issued for PLSE hit a ceiling of $63.5 million in Q2 2025 and a floor of -$58.8 million in Q4 2024.
Median Shares Issued over the past 5 years was $8.3 million (2021), compared with a mean of $10.8 million.
Biggest five-year swings in Shares Issued: plummeted 14980.51% in 2024 and later skyrocketed 705655.56% in 2025.
Pulse Biosciences' Shares Issued stood at $8.3 million in 2021, then crashed by 272.56% to -$14.4 million in 2022, then skyrocketed by 102.74% to $395000.0 in 2023, then plummeted by 14980.51% to -$58.8 million in 2024, then surged by 120.42% to $12.0 million in 2025.
The last three reported values for Shares Issued were $12.0 million (Q4 2025), $63.5 million (Q3 2025), and $63.5 million (Q2 2025) per Business Quant data.